Sentences with phrase «pediatric stem cell»
Steven P. Margossian, MD, PhD Senior Physician, Stem Cell Transplant Center Dr. Margossian is a member of one of the largest pediatric stem cell transplant centers in the country and excels at helping children and families adjust during diagnosis and treatment.
http://www.danafarberbostonchildrens.org/
Many pediatric stem cell transplant and oncology outpatients have central lines to deliver chemotherapy and other medications.
Not exact matches
Current supported funding areas at NINDS and NIMH include counterterrorism and neuroscience research, neural prosthesis program, neural stem cells, adult and pediatric translational research and treatment development, and the NIH neuroscience Blueprint.
Senior author on the paper, Deepak Srivastava, MD, director of cardiovascular and stem cell research at Gladstone and a pediatric cardiologist at the University of California San Francisco (UCSF), had previously discovered that disruption of one of two copies of a master gene called NOTCH1 can cause valve birth defects and CAVD.
He carried out pediatric hematology / oncology clinical training at the Dana - Farber Cancer Institute and Boston Children's Hospital, where he also did his postdoctoral training in stem cell biology.
Abatacept, when added to the standard drug regimen used to prevent GvHD, reduced the occurrence of acute, grade III - IV GvHD from 32 to 3 percent in pediatric and adult patients who underwent mismatched unrelated donor stem cell transplants to treat advanced cancer and other blood disorders.
Longaker, a biologist and pediatric craniofacial surgeon at Stanford University Medical Center, figured these multipotent cells — a kind of stem cell — might be useful for treating bone fractures and defects.
The two genes are known to cause a type of pediatric glaucoma by affecting the normal migration of vital stem cells to the eye.
November 30, 2006 Stem cell expert to enhance pediatric hematology / oncology programs at the University of Chicago Medical Center John Cunningham, MD, a leader in treating hemoglobinopathies and genetic blood disorders, has accepted a position with pediatric hematology / oncology and stem cell transplantation at the University of Chicago Medical Center, effective DecembeStem cell expert to enhance pediatric hematology / oncology programs at the University of Chicago Medical Center John Cunningham, MD, a leader in treating hemoglobinopathies and genetic blood disorders, has accepted a position with pediatric hematology / oncology and stem cell transplantation at the University of Chicago Medical Center, effective Decembestem cell transplantation at the University of Chicago Medical Center, effective December 1.
Because a large portion of pediatric oncology and stem cell transplant patients» care occurs in ambulatory settings, the consortium is now focusing on understanding and reducing CLABSIs that originate in the home, between outpatient clinic visits.
John Cunningham, MD, a leader in treating hemoglobinopathies and genetic blood disorders, has accepted a position with pediatric hematology / oncology and stem cell transplantation at the University of Chicago Medical Center, effective Dec. 1.
Strengthen physical assessment skills essential for the care of pediatric and adolescent oncology, hematology and stem cell transplant patients
Experts in pediatric oncology, pediatric surgery, cell and gene therapy including stem cell transplant, radiation oncology, pediatric anesthesia, pharmacology, social work, child life and the full complement of pediatric subspecialty services put a strong focus on family - centered care and emotional support for both the child and the family.
«These insights will lead to new treatments by hindering a cancer's ability to survive,» said John Cunningham, MD, section chief of pediatric hematology / oncology and professor of pediatrics, physiology and stem cell research.
Low - Dose ATLG Prevents GVHD in Pediatric Hematologic Malignancies: A newly published randomized phase III study of pediatric patients showed lower doses of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children with hematologic malignancies undergoing allogeneic hematopoietic stem cell transplantation from an unrelated donor.
When the researchers inserted that mutation into mice, the result was an undifferentiated pediatric sarcoma (cancer of connective tissue), as might be expected due to the arrest of the stem cell's development caused by the K36 mutation.